Recent Oncology/Hematology Research for March 2025
Synovial Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Cancer Anorexia-Cachexia Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Malignant Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Oncology/Hematology
| Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: AIDS, HIV & STDs, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Prescription Drugs, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| In Vitro Diagnostics Market by Product and Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Infectious Disease), End User (Hospitals, Clinics) - Forecast to 2027
Topics: Diabetes, Hematology & Oncology, Immunoassays, Oncology/Hematology
Regions: Global
| U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
Topics: Drug Development, Clinical Trial, CNS/Neurology, Oncology/Hematology
Regions: United States, Global
| Hodgkin Lymphoma (Oncology) - Drugs In Development, 2021
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Leiomyosarcoma (Oncology) - Drugs In Development, 2021
Topics: Drug Discovery, Oncology/Hematology
| Thyroid Cancer (Oncology) - Drugs In Development, 2021
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Hypopharyngeal Cancer (Oncology) - Drugs In Development, 2021
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Malignant Mesothelioma (Oncology) - Drugs In Development, 2021
Topics: Drug Discovery, Oncology/Hematology
| Kaposi Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: AIDS, HIV & STDs, Cancer Treatment, Clinical Trial, Oncology/Hematology
| Global Oncology Information Systems Market 2022-2026
Topics: Hematology & Oncology, Oncology/Hematology
Regions: Global
| HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
Topics: Genomics, Cancer Treatment, Women's Health, Oncology/Hematology
| Global Cancer Supportive Care Market 2023-2027
Topics: Cancer Treatment, Oncology/Hematology
Regions: Global
| Global Bispecific Antibodies for Cancer Market 2023-2027
Topics: Antibody Technologies, Oncology/Hematology
Regions: Global
| Community Oncology Services Global Market Opportunities And Strategies To 2032
Topics: Hospitals & Clinics, General Facilities, Physicians' Offices, Hematology & Oncology, Oncology/Hematology
Regions: Global
| Precision Cancer Therapeutics, 2022
Topics: Antibody Technologies, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Asia Pacific Medical Terahertz Technology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Terahertz Imaging and Terahertz Spectroscopy) and Application (Oncology, Dentistry, Dermatology, Tomography, Biochemistry, and Others)
Topics: COVID-19/Coronavirus, PET (Positron Emission Tomography), Oncology/Hematology, Dermatology
Regions: Asia, Oceania
| South & Central America Medical Terahertz Technology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Terahertz Imaging and Terahertz Spectroscopy) and Application (Oncology, Dentistry, Dermatology, Tomography, Biochemistry, and
Topics: COVID-19/Coronavirus, Hematology & Oncology, PET (Positron Emission Tomography), Dentistry/Oral, Oncology/Hematology, Dermatology
Regions: Central America
| Brain Cancer - Epidemiology Forecast to 2030
Topics: Cancer Treatment, Oncology/Hematology
Regions: Global
| The Value of a Modern Data Infrastructure to Accelerate Clinical Diagnosis: The Case of Munich Leukemia Laboratory
Topics: Cancer Treatment, Hospitals & Clinics, Cloud Computing, Oncology/Hematology
| Nasopharyngeal Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Topics: Cancer Treatment, Clinical Trial, Oncology/Hematology
| Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Topics: Cancer Treatment, Clinical Trial, Oncology/Hematology
| B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Topics: Cancer Treatment, Clinical Trial, Oncology/Hematology
Regions: Global
| Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
Including: 1) By Type: Hemophilia; Blood Products; Anemia and Other Blood Disorder Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/D
Topics: Blood Diseases, COVID-19/Coronavirus, Hospitals & Clinics, Generics Drugs, Over-the-Counter Drugs, Prescription Drugs, Oncology/Hematology
Regions: Global
| In Vitro Diagnostics (IVD) Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Coagulation), Manufacturer (Third party, OEM), End Users (Hospitals, Lab, Research) - Global Forecast to 2027
Topics: Hospitals & Clinics, Hematology & Oncology, Immunoassays, Microbiology & Virology, Coagulation, Lab Testing Services, Oncology/Hematology
Regions: Global
| Biomarkers Market by Product & Service (Consumable, Service, Software), Type (Safety, Efficacy, Validation), Disease (Cancer, Infectious, Neurological), Application (Diagnostics, Drug Discovery, Personalized Medicine), Region - Global Forecast to 2028
Topics: Drug Development, Biomarkers, Personalized Medicine, Oncology/Hematology
Regions: Global
| Oncology Drugs Global Market Briefing 2023
Topics: Drug Development, Prescription Drugs, Drug Discovery, Oncology/Hematology
Regions: Global
| Novel T-Cell Immunotherapies Market: Focus on ?d T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells and T-Cell Vaccines - Distribution by Type of T-cell Therapy (Activated T-cell, T-cell Vaccine, Treg and Virus-driven T-cell), Target Indications (Br
Topics: Stem Cell, Diabetes, Cancer Treatment, Diabetes, Vaccines, Oncology/Hematology
Regions: Asia, Europe, North America, Oceania, Global
| TCR-based Therapies Market by Target Indications (Bladder Cancer, Multiple Myeloma, Ovarian Cancer, Nasopharyngeal Carcinoma, Acute Myeloid Leukemia and Sarcoma), Target Antigens (NY-ESO-1, p53, WT-1 and EBV), Key Players and Key Geographies (North Americ
Topics: Research & Development, Cancer Treatment, Research & Development, Oncology/Hematology, Obstetrics/Gynecology
Regions: Asia, Europe, North America, Oceania, Global
| TIL-based Therapies Market by Target Indications (Melanoma, Head and Neck Cancer, Breast Cancer, Hepatocellular Cancer, Sarcoma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, and Cervical Cancer), Key Players and Key Geographies (North Ameri
Topics: Research & Development, Cancer Treatment, Research & Development, Oncology/Hematology
Regions: Asia, Europe, North America, Oceania, Global
| DNA Damage Response Targeting Therapeutics (beyond PARP Inhibitors) Market by Target Disease Indication (Acute Myeloid Leukemias, COVID-19, Diabetic Macular Edemas, Mesotheliomas, Myelodysplastic Syndromes, Non-Squamous Non-Small Cell Lung Cancers, Prosta
Topics: Research & Development, Drug Development, Biologics, Cancer Treatment, COVID-19/Coronavirus, Drug Discovery, Clinical Trial, Women's Health, Oncology/Hematology, Men's Health
Regions: South Korea, Singapore, Denmark, Germany, Spain, United Kingdom, Canada, Australia, Global
| HER2 Targeting Therapies Market, 2021-2031
Topics: Antibody Technologies, Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
| Antibody Drug Conjugates Market (6th Edition), 2021-2030 Distribution by Target Indication (Breast cancer, Blood cancer, Colorectal cancer, Gastric cancer, Gynecological cancer, Head and neck cancer, Lung cancer, and Others), Type of Linker Used (VC, Sulf
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America, Global
| RAS Targeting Therapies Market, 2021-2031
Topics: Drug Development, Cancer Treatment, Oncology/Hematology
|
Prev | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
